Cochrane Abstracts
Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risperidone for Attention‐deficit Hyperactivity Disorder in People With Intellectual Disabilities." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432949/all/Risperidone_for_attention‐deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities.
Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432949/all/Risperidone_for_attention‐deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities. Accessed January 21, 2025.
Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432949/all/Risperidone_for_attention‐deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities
Risperidone for Attention‐deficit Hyperactivity Disorder in People With Intellectual Disabilities [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432949/all/Risperidone_for_attention‐deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risperidone for attention‐deficit hyperactivity disorder in people with intellectual disabilities
ID - 432949
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432949/all/Risperidone_for_attention‐deficit_hyperactivity_disorder_in_people_with_intellectual_disabilities
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
